Multiple Disease-Modifying Drugs Increase Surgical Risk in Ulcerative Colitis

Study finds using multiple disease-modifying drugs in ulcerative colitis increases risk of surgical resection. Each additional drug significantly raises likelihood of surgery, highlighting importance of patient counseling. However, postoperative risk of complications, ER visits, and readmissions remain unaffected by number of drugs used. Findings offer crucial prognostic insights for clinicians managing UC patients.